hotspot -WSS

hotspot

author：explore 2025-09-28 01:35:27 - browse：5

President Biden speaks on the Cancer Moonshot initiative at the John F. Kennedy Library in 2022. Evan Vucci/AP

WASHINGTON — The next chapter of President Biden’s moonshot to end cancer has landed. While the new goals are inspiring hope among cancer researchers, not everyone is impressed.

The president early Wednesday morning unveiled a slew of federal plans and private-sector agreements to fuel the relaunched Cancer Moonshot, a project to improve treatments and halve cancer deaths in the next 25 years. Among roughly 50 new programs and partnerships are multimillion-dollar pledges to advance testing, data pools, clinical trials and outreach efforts.

It is the latest phase of a project Biden first launched as vice president in the wake of his son Beau’s death from brain cancer in 2015. But while the first moonshot funneled money almost entirely to early-stage cancer research, its sequel is broadening efforts to prevent cancer deaths — particularly through anti-smoking efforts — and introduces a new focus on research infrastructure and patient engagement that some cancer researchers have applauded.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： STAT Report: Patient voices and perspectives

explore

WSS

Clinicians often fail to acknowledge the pain caused by long Covid

Some medical students still think black patients feel less pain

UHS says company favors patients whose insurance pays more

Device maker Teleflex to acquire urology company for $600M

Ozempic cut risk of death in diabetes patients with chronic kidney disease

Roche’s Alnylam deal shows drug firms interested in heart drugs

focus

hotspot

leisure time

Guidelines to prevent youth baseball injuries need more muscle

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

Supreme Court strikes down use of affirmative action

Medical students need to learn the potent medicine of empathy

After affirmative action ruling, medical educators look to 'holistic review'

Device maker Teleflex to acquire urology company for $600M

Medical leaders decry Supreme Court decision on affirmative action

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Protect nursing home residents from future pandemics

entertainment

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

Beyond aggravation: Constipation is an American epidemic

Stroke rates rising, especially in working

Device maker Teleflex to acquire urology company for $600M

The Bio Revolution is changing business and society

Asahi Kasei to buy Calliditas, picking up kidney disease drug

focus

explore

Wikipedia

Wikipedia